BioReliance and SAFC will close out the month of January in Washington, DC with attendance at two industry events.
First, the team will attend the Phacilitate Cell and Gene Therapy Forum from January 27 – 29, at the Grand Hyatt where influencers in the cell therapy, gene therapy and tissue engineered product sector will come together. SAFC will be onsite at Booth 48 to highlight the Carlsbad manufacturing capabilities and BioReliance testing services for gene therapies and viral vaccines.
Dave Backer, Senior Director & General Manager at SAFC, will participate in a panel discussion on cancer vaccines at 3:40 pm on Monday, January 27. The panel will focus on “Learning from past successes and failures to deliver game-changing efficacy.”
Backer will also participate in the Immunotherapy forum within the session “Will stunning clinical results translate to commercial success for the next wave of Immunotherapy products?” on Tuesday, January 28 at 10:25 am.
BioReliance will also attend the CASSS – WCBP Symposium on the interface of regulatory analytical sciences for biotechnology health projects from January 28 – 30, at the Mayflower Hotel.
The team at CASSS will highlight BioReliance’s bioanalytical capabilities at Table 26.
To learn more about SAFC services, click here.
To learn more about BioReliance services, click here.